The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Just to reaffirm the facts. The Innova test is completely exempt from future tightening of the requirements in the UK. Completely exempt.
It’s covered until 2023 by the 800 million Inova tests the gov have in their possession. They were delivered in April. In March Jim Bethel tweeted they were using ODX and Mologic. Something went wrong. Look at the SP.
PL75 I was talking about the EU. Try breaking into that. There is no UK market with the government sitting on 800 million Innova tests and a full exemption from future regs.
Chart I posted on Twitter had it hitting 203p before the presentation. There is another level at 173p.
By now, professionals have been using their test of choice for months. Supply chains have been formed, trust has been gained. AVCT have to break those chains. Never an easy thing.
Sounds like orders are expected shortly.
ODX up too. Inside info on the Innova extension? All test stocks will spike big time if it’s not extended.
https://www.investorschronicle.co.uk/shares/2019/12/13/avoid-aim-s-traps/
Bulletin board providers are popular among many private investors – some of whom are incredibly well researched, and some of whom (to put it politely) aren’t. At the lower end of the market, these boards are used to encourage the naïve to buy into a stock. There are many who have multi-IDs who then literally have a conversation with themselves, in an attempt to generate excitement around the stock.
Should anyone post a contrasting opinion – they are called out as a ‘shorter’ or a ‘deramper’ and are the subject of abuse. Worse still, the group encourages everyone to ‘report’ the post in an attempt to have the post automatically deleted. This means that anyone viewing the board will only see one positive narrative because the posts that are automatically deleted are not reviewed by anyone. Those who own the bulletin boards don’t care about the actual content of the posts, because they’re not monetising the boards. What they monetise is the volume of traffic on the site, which they then sell in the form of advertisements and impressions. So, while the bulletin boards are free to use, there is almost no point in using them.
It’s been over 200p and back under 100p twice in 12 months. Surely you don’t just sit on your hands. Can’t be genuine.
Exactly this. If he announces zero orders and uses words like, shortly, tough, unexpected, looking forward, difficult, vaccine, it’ll drop below 200p. There’s nothing to do but wait and see.
On my chart it was going to 203p. (SP was 226p). It would have hit but sentiment returned with the FDA and Innova. Chart is still valid. I’ve set an alert for 210p.
Of course it’s the shorters. Nothing to do with Mologic suing the government. The level of delusion is unbelievable.
Naive in the extreme to believe the drop is by derampers. It’s to do with the fact the Mologic test failed at Porton Down and is not going to be used by the gov as a result. Along with the AVCT test also failing, the market is simply saying where is the revenue coming from to justify the huge MCAP.
The gov essentially paid ODX £50 million, to be fully staffed and ready to go should they be required in the next 20 months. Plan B for the tiny figure of £50 million. At one point, months ago now, it would have been Plan A to have a sovereign test. Both avacta and Mologic failing to pass PD made this impossible. Innova building a factory in the UK, with gov subsidies, was a clear indication the sovereign test idea had failed and been abandoned.
Unbelievable. They’re not going to declare a sovereign test. It’s Innova. It always has been. There is no other test that passed PD and can be manufactured in the billions. I’ll give you more news. The USA and EU are awash with rapid LFT. You believe an AIM CEO at your own risk.
It’s caused an awful lot of arguments this but the arguments are done now. The Mologic test failed at Porton Down with PD claiming a failure rate greater than 30%. The test is not waiting on approval and Mologic are now suing, effectively ending their involvement with the gov. AVCT have already RNSd the failure of their test due to the use of frozen samples. It was always the intention of the gov to stick with Innova, hence the new factory in Wales. It’s an absolute disgrace but there it is.
82p was the lowest I paid. 2nd share I ever bought. I was £45k up within about 6 weeks of starting trading. And then I learned what a placing was and how certain people could be informed about it beforehand so they could sell and buy back later. I held of course and watched it disappear. Shall I continue?
The facts are there and straight from the government. From a human point of view they match exactly with what I’d expect. This is my largest holding. I was buying in April 2020. I removed my £55k stake when it was clear the test failed at Porton Down. I’ve got a free run on the multiple opportunities the company has and I couldn’t be happier. It’s an awesome company with an incredible future. It’s just not going to sell many LFT to the UK gov. No big deal.
Mate, HMG have enough Innova tests stockpiled to last them until 2023. Look at the figures.